Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report

BACKGROUND: Gemcitabine is currently the standard chemotherapy for the adjuvant treatment of pancreatic cancer. This chemotherapeutic agent is generally well-tolerated, myelosuppression and gastrointestinal toxicity being common side effects. Nevertheless, gemcitabine-induced pulmonary toxicity has...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Fenocchio, Elisabetta, Depetris, Ilaria, Campanella, Delia, Garetto, Lucia, Schianca, Fabrizio Carnevale, Galizia, Danilo, Grignani, Giovanni, Aglietta, Massimo, Leone, Francesco
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5059971/
https://ncbi.nlm.nih.gov/pubmed/27733144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2833-9
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items